These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22123000)

  • 1. Predictors of major bleeding in peri-procedural anticoagulation management.
    Tafur AJ; McBane R; Wysokinski WE; Litin S; Daniels P; Slusser J; Hodge D; Beckman MG; Heit JA
    J Thromb Haemost; 2012 Feb; 10(2):261-7. PubMed ID: 22123000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients.
    Attaya H; Wysokinski WE; Bower T; Litin S; Daniels PR; Slusser J; Heit JA; McBane RD
    J Thromb Thrombolysis; 2013 Jan; 35(1):100-6. PubMed ID: 22843195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
    Daniels PR; McBane RD; Litin SC; Ward SA; Hodge DO; Dowling NF; Heit JA
    Thromb Res; 2009 Jul; 124(3):300-5. PubMed ID: 19232682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
    Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
    Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural Anticoagulation Management of Patients with Thrombophilia.
    Wysokinska EM; Wysokinski WE; Ketha S; Litin S; Daniels P; Slusser J; Hodge DO; Heit JA; McBane RD
    Am J Med; 2016 Sep; 129(9):986-92. PubMed ID: 27235004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin bridging in warfarin anticoagulation therapy initiation could increase bleeding in non-valvular atrial fibrillation patients: a multicenter propensity-matched analysis.
    Kim TH; Kim JY; Mun HS; Lee HY; Roh YH; Uhm JS; Pak HN; Lee MH; Joung B
    J Thromb Haemost; 2015 Feb; 13(2):182-90. PubMed ID: 25472735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients.
    Tafur AJ; Wysokinski WE; McBane RD; Wolny E; Sutkowska E; Litin SC; Daniels PR; Slusser JP; Hodge DO; Heit JA
    Ann Oncol; 2012 Aug; 23(8):1998-2005. PubMed ID: 22473596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement.
    Mathew JG; Spyropoulos AC; Yusuf A; Vincent J; Eikelboom J; Shestakovska O; Fremes S; Noora J; Guo L; Peterson M; Pai M; Whitlock R
    Thromb Haemost; 2014 Dec; 112(6):1120-8. PubMed ID: 25183209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-procedural antithrombotic management: time to burn the bridge?
    Marquez J; Togami JC; Dant CR; Herrera A; Marshik P; Burnett AE
    J Thromb Thrombolysis; 2018 Apr; 45(3):337-344. PubMed ID: 29383558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis.
    Schulman S; Zondag M; Linkins L; Pasca S; Cheung YW; de Sancho M; Gallus A; Lecumberri R; Molnar S; Ageno W; Le Gal G; Falanga A; Hulegårdh E; Ranta S; Kamphuisen P; Debourdeau P; Rigamonti V; Ortel TL; Lee A
    J Thromb Haemost; 2015 Jun; 13(6):1010-8. PubMed ID: 25851122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-dimer to guide the intensity of anticoagulation in Chinese patients after mechanical heart valve replacement: a randomized controlled trial.
    Zhang L; Zheng X; Long Y; Wu M; Chen Y; Yang J; Liu Z; Zhang Z
    J Thromb Haemost; 2017 Oct; 15(10):1934-1941. PubMed ID: 28762606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.
    Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F
    J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and total costs of outpatient vs. inpatient peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
    Attaya H; Shah ND; Wysokinski WE; Van Houten HK; Heit JA; McBane RD
    Int J Cardiol; 2013 Oct; 168(6):5311-5. PubMed ID: 23998551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial.
    Essebag V; Proietti R; Birnie DH; Wang J; Douketis J; Coutu B; Parkash R; Lip GYH; Hohnloser SH; Moriarty A; Oldgren J; Connolly SJ; Ezekowitz M; Healey JS
    Europace; 2017 Oct; 19(10):1630-1636. PubMed ID: 28339794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
    Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
    Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
    Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periprocedural anticoagulation management of patients with venous thromboembolism.
    McBane RD; Wysokinski WE; Daniels PR; Litin SC; Slusser J; Hodge DO; Dowling NF; Heit JA
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):442-8. PubMed ID: 20139361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.